2型糖尿病患者草药使用安全性系统评价与 meta 分析
BACKGROUND: Herbal medicines (HM) use among type 2 diabetes mellitus (T2DM) patients has grown tremendously despite the existence of conventional treatments. However, evidence on their safety, potential side effects, and interactions remains scarce.…
要点
- 2型糖尿病患者草药使用全球合并患病率为53%,非洲区域占全球使用的39.8%。
- 49种鉴定草药中7种为禁忌、19种需谨慎、23种可安全使用,12种有潜在药物相互作用。
- 临床应避免禁忌草药,并建议患者在医疗从业者监督下使用草药。
核心结论
- 草药在2型糖尿病患者中全球广泛使用,但多种草药存在安全性问题,需避免禁忌草药并寻求医疗从业者监督以保障患者安全。
主要发现
- 2型糖尿病患者草药使用全球合并患病率为53%,存在显著地区差异;非洲区域使用占全球的39.8%。
- 共鉴定49种草药,最常用为 Opuntia ficus-indica L.、Trigonella foenum graecum L.、Allium sativum L. 和 Cinnamomum verum J.。
- 安全性分类显示7种草药为禁忌、19种需谨慎、23种可安全使用;另有12种草药报告潜在药理相互作用。
关键数值与推荐
- 草药使用全球合并患病率53%,非洲区域占全球使用的39.8%。
- 49种鉴定草药中7种禁忌、19种需谨慎、23种安全,12种有潜在药物相互作用。
临床怎么用
- 临床接诊2型糖尿病患者时应主动询问草药使用情况,避免推荐或允许使用禁忌草药。
- 对需谨慎使用的草药及有潜在相互作用的草药,建议在医疗从业者监督下使用并监测不良反应。
局限性
- 纳入研究均为横断面设计,可能影响因果推断及安全性证据的强度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Herbal medicines (HM) use among type 2 diabetes mellitus (T2DM) patients has grown tremendously despite the existence of conventional treatments. However, evidence on their safety, potential side effects, and interactions remains scarce. This systematic review and meta-analysis aim to determine the global prevalence of HM use among T2DM patients and assess the safety and potential interactions. METHODS: A systematic search of four electronic databases was conducted until March 2024. Data were extracted and then assessed through an adapted quality appraisal tool. A meta-analysis estimated the pooled prevalence of HM use among T2DM patients and examined predictors of use. Identified herbs were classified based on safety and potential interactions with pharmacological treatments. The study followed PRISMA guidelines. RESULTS: Twenty-two cross-sectional studies from 19 countries were included. The global prevalence of HM use among T2DM patients was 53%, with significant regional variations. The highest prevalence of HM use among T2DM patients is in the African region, accounting for 39.8% of global HM use. Among 49 identified herbs, Opuntia ficus-indica L., Trigonella foenum graecum L., Allium sativum L., and Cinnamomum verum J. were the most commonly used. The safety classification reported 7 contraindicated herbs and 19 requiring caution, and 23 considered safe for use. Additionally, 12 herbs reported potential pharmacological interactions. CONCLUSIONS: Although the use of HM is widespread globally, multiple herbs pose safety concerns. Therefore, to preserve patients' safety, it is essential to avoid using contraindicated herbs and to seek healthcare practitioner supervision.
引用
- Boulares E, Bragazzi NL, Yin TSC, et al. Assessing the safety of herbal medicine use among type 2 diabetes mellitus patients: A systematic review and meta-analysis. Complement Ther Med. 2026. PMID: 41539457. doi:10.1016/j.ctim.2026.103319
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。